Riskpilot← Back to searchSign inGet full accessL Med AB
ABActiveOrg 5590083324Kvarngärdesgatan 1 BGeneral medical practice activities · NACE 8621Est. 20151 employees
Revenue 2025
SEK 767K
+15% vs 2024
EBITDA margin
32.9%
+98% vs 2024
Equity ratio
51.5%
Financial strength
Net profit 2025
SEK 149K
+49% vs 2024
| Revenue | SEK 767K | +15% |
| EBITDA | SEK 253K | +98% |
| Net profit | SEK 149K | +49% |
| Total assets | SEK 422K | +13% |
| Equity | SEK 217K | +29% |
| Employees | 1 | — |
Legal name
L Med AB
Org number
5590083324
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 mars 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva vård- och omsorgsverksamhet i den privata- och kommunala sektorn. Konsultverksamheten innefattar även utbildning, undervisning och föreläsningsverksamhet. Resor och boende som krävs för att fullgöra ovanstående verksamhet står bolaget för. Dessutom handel och förvaltning av värdepapper och fast egendom samt förenlig verksamhet.
Address
Kvarngärdesgatan 1 B
Email
jon.lindgren87@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 984 | 768 | 932 | 666 | 767 |
| Staff expenses | — | −337 | −673 | −395 | −391 |
| EBITDA | 245 | 269 | 198 | 128 | 253 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 245 | 269 | 198 | 128 | 253 |
| Net financials | — | −0 | −0 | −1 | −52 |
| Profit before tax | 285 | 202 | 198 | 127 | 201 |
| Tax | −59 | −42 | −41 | −27 | −52 |
| Net profit | 226 | 160 | 156 | 100 | 149 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 744 | 691 | 657 | 373 | 422 |
| Equity | 291 | 261 | 218 | 168 | 217 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 454 | 363 | 372 | 137 | 137 |
| Total debt | 454 | 363 | 372 | 137 | 137 |
EBITDA margin
32.9%
This company
15.8%
Market median
+108% vs market
20212025
Equity ratio
51.5%
This company
38.2%
Market median
+35% vs market
20212025
Return on equity
68.5%
This company
18.4%
Market median
+272% vs market
20212025
Net profit margin
19.4%
This company
8.1%
Market median
+140% vs market
20212025
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20212025
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of L Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Fredrik Saleem Lindgren | Board of Directors | 0 companies |
| Beth Kari Maria Lindgren | Deputy Board Member | 0 companies |